174 related articles for article (PubMed ID: 2590984)
1. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
2. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
[TBL] [Abstract][Full Text] [Related]
3. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
5. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the tumor regression rate of 127 uveal melanomas irradiated with 106 Ru/106 Rh. Attempted analysis of the correlations between per-operative cytology and histopathology of the enucleated eye and the tumoral regression on the one hand, and general prognosis on the other hand].
Grange JD; Thacoor S; Bievelez B; Jean-Louis B; Baute B; Gérard JP; Sentenac I; Fontanière B; Bailly C
Ophtalmologie; 1990; 4(3):221-4. PubMed ID: 2250951
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanomas of the choroid and ruthenium applicators.
Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
[TBL] [Abstract][Full Text] [Related]
8. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
10. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
[TBL] [Abstract][Full Text] [Related]
11. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
12. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
Pe'er J; Averbukh E; Frenkel S
Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
[No Abstract] [Full Text] [Related]
13. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
Razzaq L; de Keizer RJ
Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
[No Abstract] [Full Text] [Related]
14. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases].
Foerster MH; Bornfeld N; Wessing A; Schulz U; Schmitt G; Meyer-Schwickerath G
Klin Monbl Augenheilkd; 1984 Dec; 185(6):490-4. PubMed ID: 6527503
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
17. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
18. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation].
Guthoff R; Frischmuth J; Jensen OA; Bjerrum K; Prause JU
Klin Monbl Augenheilkd; 1992 Apr; 200(4):257-61. PubMed ID: 1614086
[TBL] [Abstract][Full Text] [Related]
19. [Visual acuity after surgical management of ciliary body melanoma].
Romanowska-Dixon B
Klin Oczna; 2005; 107(10-12):632-4. PubMed ID: 16619807
[TBL] [Abstract][Full Text] [Related]
20. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
Kleineidam M; Guthoff R
Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]